Cellular Senescence Is a Central Driver of Cognitive Disparities in Aging
Open Access
- 12 March 2025
- journal article
- Published by Wiley in Aging Cell
- Vol. 24 (6) , e70041
Abstract
Cognitive function in aging is heterogeneous: while some older individuals develop significant impairments and dementia, others remain resilient and retain cognitive function throughout their lifespan. The molecular mechanisms that underlie these divergent cognitive trajectories, however, remain largely unresolved. Here, we utilized a high‐resolution home‐cage‐based cognitive testing paradigm to delineate mechanisms that contribute to age‐related cognitive heterogeneity. We cognitively stratified aged C57Bl/6N male mice by cognitive performance into intact (resilient) or impaired subgroups based on young performance benchmarks. Cognitively impaired males exhibited marked reactive gliosis in the hippocampus, characterized by microglial activation, increased astrocyte arborization, and elevated transcriptional expression of reactivity markers. These changes were accompanied by increased markers of cellular senescence and the associated senescence‐associated secretory phenotype (SASP) in impaired animals, including p16 INK4a , SASP factors (e.g., Il‐6 , Il‐1b , Mmp3 ), and SA‐β‐gal staining in the hippocampus. Notably, clearance of senescent cells using senolytic agents dasatinib and quercetin ameliorated the heterogeneity in cognitive performance observed with age and attenuated impairment‐associated gliosis, senescence markers, and mitochondrial dysfunction. Aged female mice could not be stratified into subgroups yet showed increased neuroinflammation with age that was not resolved with senolytics. Collectively, our findings implicate cellular senescence as a central driver of sex‐specific neuroinflammation that drives divergent cognitive trajectories in aging. Thus, we demonstrate that senolytic treatment is an effective therapeutic strategy to mitigate cognitive impairment by reducing neuroinflammation and associated metabolic disturbances.Keywords
Funding Information
- National Institute on Aging (R00AG056662)
- National Institute on Aging (R01AG085398)
- National Institute on Aging (T32AG052363)
- National Institute of General Medical Sciences (P20GM125528)
This publication has 67 references indexed in Scilit:
- Decision-making under uncertainty in healthy and cognitively impaired aging: A systematic review and meta-analysisArchives of Gerontology and Geriatrics, 2024
- Guidelines for minimal information on cellular senescence experimentation in vivoCell, 2024
- Defining exceptional cognition in older adults: A systematic review of cognitive super‐ageingInternational Journal of Geriatric Psychiatry, 2023
- Cellular senescence in brain aging and neurodegenerationAgeing Research Reviews, 2023
- Cellular Senescence and the Senescence-Associated Secretory Phenotype as Drivers of Skin PhotoagingJournal of Investigative Dermatology, 2021
- Normal aging induces PD-1-enriched exhausted microglia and A1-like reactive astrocytes in the hypothalamusBiochemical and Biophysical Research Communications, 2021
- Aging, Cell Senescence, and Chronic DiseaseJAMA, 2018
- Cellular Senescence Is Induced by the Environmental Neurotoxin Paraquat and Contributes to Neuropathology Linked to Parkinson’s DiseaseCell Reports, 2018
- The Hallmarks of AgingCell, 2013
- Age‐related differences in the functional connectivity of the hippocampus during memory encodingHippocampus, 2003